(Q38029146)

27 August 2017

title

Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects (English)

1 reference

27 August 2017

0 references

1 reference

C Tang

1

1 reference

27 August 2017

T Godfrey

series ordinal

2

1 reference

27 August 2017

R Stawell

series ordinal

3

1 reference

27 August 2017

M Nikpour

series ordinal

4

1 reference

27 August 2017

publication date

1 September 2012

1 reference

Internal Medicine Journal

27 August 2017

published in

1 reference

27 August 2017

volume

42

1 reference

27 August 2017

issue

9

1 reference

27 August 2017

page(s)

968-978

1 reference

Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Epidemiology of atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Targeted therapies in systemic lupus erythematosus: successes, failures and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Pharmacogenetics of disease-modifying anti-rheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Occasional series: lupus around the world systemic lupus erythematosus research in the Asia-Pacific region: a co-ordinated and co-operative approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Influence of hydroxychloroquine on the bioavailability of oral metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Cardiac glycosides. Drug interactions of clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Antimalarial drugs in the treatment of rheumatological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Biochemical characterization of ADP-ribose polymer metabolism in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Effect of medication on microvascular vasodilatation in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Vascular stiffness in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Vascular elasticity of systemic lupus erythematosus patients is associated with steroids and hydroxychloroquine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Comparative study of efficacy and safety of hydroxychloroquine and chloroquine in polymorphic light eruption: a randomized, double-blind, multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Antimalarials may influence the risk of malignancy in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

An overview of the treatment of childhood SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

New concepts in antimalarial use and mode of action in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Oral mucosal hyperpigmentation secondary to antimalarial drug therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Antimalarial drugs for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Humphrey visual field findings in hydroxychloroquine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Chloroquine neuromyotoxicity. Clinical and pathologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Cardiomyopathy related to antimalarial therapy with illustrative case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Drug-induced haemolysis and renal failure in children with glucose-6-phosphate dehydrogenase deficiency in Afghanistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Hydroxychloroquine in lupus pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: A study of one hundred thirty‐three cases compared with a control group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Therapy insight: the use of antirheumatic drugs during nursing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Anti-inflammatory and immunosuppressive drugs and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Transfer of drugs and other chemicals into human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02886.X

10.1111/J.1445-5994.2012.02886.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference